Related Experiment Video
Updated: Mar 29, 2026
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Management of hemodialysis catheter-induced cavoatrial junction lesion by VBX stent-graft
Hai Yu1,2, Xuedong Bao1, Daqing Li2
1Department of Vascular Surgery, LongHua Hospital of Shanghai University of Traditional Chinese Medicine, ShangHai, China.
Insights
Viabahn VBX stent grafts effectively treat hemodialysis catheter-induced cavoatrial junction (CAJ) stenosis or occlusion. This endovascular therapy achieved a 100% technical success and primary patency rate, alleviating superior vena cava (SVC) syndrome symptoms safely.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Nephrology
Background:
- Catheter-induced cavoatrial junction (CAJ) stenosis/occlusion causes severe superior vena cava (SVC) syndrome.
- It limits upper extremity vascular access for hemodialysis patients.
- Endovascular therapy for CAJ lesions has high restenosis and complication risks.
Purpose of the Study:
- To evaluate the technical and clinical outcomes of Viabahn VBX stent grafts for CAJ reconstruction.
- To assess the safety and efficacy of VBX stent grafts in hemodialysis patients with SVC syndrome.
Main Methods:
- Retrospective analysis of 12 patients with catheter-induced CAJ lesions treated with VBX stent grafts.
- Data collected included demographics, clinical presentation, technical details, and outcomes.
- Follow-up assessed primary patency and symptom resolution.
Main Results:
- 100% technical success rate with no complications in 12 patients (8 female, 4 male; mean age 48.3 years).
- Stenosis (5 cases) or occlusion (7 cases) of the CAJ were treated.
- All patients experienced symptom alleviation post-procedure; 100% primary patency at mean 18.9 months follow-up.
Conclusions:
- Viabahn VBX stent-graft reconstruction is a safe and effective treatment for CAJ lesions.
- This method successfully avoids major fatal complications associated with CAJ interventions.
- VBX stent grafts offer a promising solution for managing hemodialysis-related CAJ complications.
Background:
Hemodialysis catheter-induced cavoatrial junction (CAJ) stenosis or occlusion is a potentially severe condition. It not only leads to severe symptoms of superior vena cava (SVC) syndrome but also limits the establishment of vascular access in the upper extremities of hemodialysis patients. Endovascular therapy is the first-line treatment but has a high restenosis rate and potential fatal risks such as SVC rupture, cardiac tamponade, and stent malposition or migration during the procedure. Few studies focusing on CAJ management have been reported.
Objective:
We evaluated the technical and clinical outcomes of Viabahn VBX stent grafts used for reconstructing the CAJ lesion in hemodialysis patients with SVC syndrome.
Methods:
We retrospectively analyzed 12 patients with catheter-induced CAJ lesions who were treated with VBX stent grafts. Demographic data, clinical signs and symptoms, technical details, and clinical outcomes were recorded.
Results:
The study included 8 females and 4 males, with a mean age of 48.3 ± 12.3 years (age range: 28-62 years). High-grade stenosis of the CAJ was detected in five cases, while occlusion was observed in seven cases, and among them, one case had an indwelling tunneled central catheter (TCC). The technical success rate was 100%, without any complications. After stent deployment, symptoms were alleviated in all cases. During the follow-up period (mean follow-up time of 18.9 ± 6.0 months), the primary patency rate of the target lesion at the CAJ reached 100%.
Conclusions:
Using a VBX stent-graft is a safe and effective method to treat CAJ lesion avoiding major fatal complication.
Related Concept Videos
01:25Hemodialysis I: Introduction
01:24Hemodialysis II: Procedure and Complications
01:26Cardiac Catheterization IV: Nursing Management